![]() |
市場調查報告書
商品編碼
1666890
生命徵象監測設備市場機會、成長動力、產業趨勢分析與 2025 - 2034 年預測Vital Sign Monitoring Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024 年全球生命徵象監測設備市場規模達到 56 億美元,預計將經歷大幅成長,2025 年至 2034 年的複合年成長率為 8.2%。這些設備透過提供心率、血壓和氧氣水平等關鍵參數的即時資料,在管理患者健康方面發揮著至關重要的作用。
隨著全球醫療保健系統努力推行更積極主動的照護模式,對生命徵象監測設備的需求預計將會激增。無線和攜帶式解決方案等技術創新也促進了市場的擴張,為醫療保健提供者和患者提供了更大的可及性和便利性。尤其是在全球大流行之後,向家庭醫療保健和遠距醫療的轉變預計將進一步推動這一成長,為市場參與者創造重大機會。
市場範圍 | |
---|---|
起始年份 | 2024 |
預測年份 | 2025-2034 |
起始值 | 56億美元 |
預測值 | 122億美元 |
複合年成長率 | 8.2% |
市場主要按產品類型細分,包括血壓監測儀、脈搏血氧儀、溫度監測設備和其他相關類別。 2024年血壓計佔據主導地位,佔整個市場佔有率的48.9%。這是由於全球高血壓及相關健康狀況的發生率不斷上升所致。這些監測器進一步細分為子類別,包括無液體監測器、數位監測器和配件。其中,數位監視器越來越受歡迎,因其易於使用、便攜性和高精度而受到廣泛關注。
按最終用戶分類,市場服務於多個領域,包括醫院和診所、家庭護理、門診手術中心等。 2024 年,醫院和診所佔最大佔有率,價值 18 億美元。這些醫療機構尤其依賴持續的生命徵象監測來管理大量患有急性和慢性疾病的患者。醫院數量的不斷增加以及醫療保健基礎設施的不斷進步進一步支持了對這些設備的需求。即時監控的需求持續上升,以確保有效的患者管理和及時的干涉。
在美國,生命徵象監測設備市場規模在 2024 年將達到 21 億美元。心血管疾病、高血壓和糖尿病等慢性疾病負擔日益加重,推動了對血壓和血氧飽和度等重要參數的持續監測的需求。對預防性醫療保健和早期診斷的重視也極大地促進了市場成長,使得生命徵象監測成為整體醫療保健方法不可或缺的一部分。
The Global Vital Sign Monitoring Devices Market reached USD 5.6 billion in 2024 and is expected to experience substantial growth, advancing at a CAGR of 8.2% from 2025 to 2034. The increasing prevalence of chronic diseases, such as hypertension, diabetes, and cardiovascular conditions, has made continuous health monitoring more essential than ever. These devices play a vital role in managing patient health by providing real-time data on critical parameters like heart rate, blood pressure, and oxygen levels.
As healthcare systems worldwide strive for more proactive care models, the demand for vital signs monitoring devices is expected to skyrocket. Innovations in technology, such as wireless and portable solutions, are also contributing to the market's expansion, providing greater accessibility and convenience for both healthcare providers and patients. The shift toward home-based healthcare and telemedicine, particularly in the wake of the global pandemic, is expected to further fuel this growth, creating significant opportunities for market players.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $5.6 Billion |
Forecast Value | $12.2 Billion |
CAGR | 8.2% |
The market is primarily segmented by product type, which includes blood pressure monitors, pulse oximeters, temperature monitoring devices, and other related categories. In 2024, blood pressure monitors took the lead, accounting for 48.9% of the total market share. This is driven by the growing incidence of hypertension and related health conditions worldwide. These monitors are further broken down into subcategories, including aneroid monitors, digital monitors, and accessories. Among these, digital monitors are becoming increasingly popular, gaining traction for their ease of use, portability, and high level of accuracy.
By end-user, the market serves a diverse range of sectors, including hospitals and clinics, homecare, ambulatory surgery centers, and others. Hospitals and clinics represented the largest share in 2024, valued at USD 1.8 billion. These healthcare facilities are particularly reliant on continuous vital signs monitoring to manage the high volume of patients dealing with both acute and chronic conditions. The growing number of hospitals, along with ongoing advancements in healthcare infrastructure, further supports the need for these devices. The demand for real-time monitoring continues to rise, ensuring effective patient management and timely interventions.
In the United States, the vital sign monitoring devices market reached USD 2.1 billion in 2024. A robust healthcare infrastructure and widespread adoption of these devices across various healthcare settings, including hospitals, clinics, and home care, are major factors behind this growth. The increasing burden of chronic diseases, such as cardiovascular issues, hypertension, and diabetes, is driving the demand for continuous monitoring of vital parameters like blood pressure and oxygen saturation. The emphasis on preventive healthcare and early diagnosis is also significantly contributing to market growth, making vital signs monitoring an integral part of the overall healthcare approach.